PPAR alpha and the regulation of cell division and apoptosis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12505304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).

  2001cited by this paper
• Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha.

  2000cited by this paper
• Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators.

  2000cited by this paper
• Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.

  2000cited by this paper
• The role of protein kinase B and mitogen‐activated protein kinase in epidermal growth factor and tumor necrosis factor α–mediated rat hepatocyte survival and apoptosis

  2000cited by this paper
• Peroxisome proliferators and carcinogenesis: editorial perspectives.

  2000cited by this paper
• G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin.

  1999cited by this paper
• Cytokines in non-genotoxic hepatocarcinogenesis.

  1999cited by this paper
• Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis.

  1999cited by this paper
• Role for tumor necrosis factor α receptor 1 and interleukin‐1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin

  1999cited by this paper
• Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).

  1998cited by this paper
• Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?

  1997cited by this paper
• Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.

  1997cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.

  1992cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator.

  1977cited by this paper

• Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway

  2024cites this paper
• Deletion of lymphotoxin-β receptor (LTβR) protects against acute kidney injury by PPARα pathway

  2024cites this paper
• PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments

  2024cites this paper
• Melatonin attenuates cisplatin-induced acute kidney injury in mice: Involvement of PPARα and fatty acid oxidation.

  2022cites this paper
• RAID: Regression Analysis–Based Inductive DNA Microarray for Precise Read-Across

  2022cites this paper
• Tumorigenic activity of alternative per- and polyfluoroalkyl substances (PFAS): Mechanistic in vitro studies.

  2021cites this paper
• Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression.

  2020cites this paper
• Protective roles of fenofibrate against cisplatin‐induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction

  2018cites this paper
• Connexin-based signaling and drug-induced hepatotoxicity

  2017cites this paper
• Peroxisome proliferator-activated receptor alpha mediates C/EBP homologous protein to protect mice from acute liver failure

  2017cites this paper
• The role of brain PPAR[gamma] in regulation of energy balance and glucose homeostasis

  2017cites this paper
• Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

  2016cites this paper
• Peroxisome Proliferator – Activated Receptor ` Protects Renal Tubular Cells from Gentamicin-Induced Apoptosis via Upregulating na + / h + exchanger nhe 1

  2016cites this paper
• Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.

  2016cites this paper
• Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure

  2016cites this paper
• Fluoxetine regulates cell growth inhibition of interferon-α.

  2016cites this paper
• Environmental Enrichment, Age, and PPARα Interact to Regulate Proliferation in Neurogenic Niches

  2016cites this paper
• Peroxisome Proliferator-Activated Receptor α Protects Renal Tubular Cells from Gentamicin-Induced Apoptosis via Upregulating Na+/H+ Exchanger NHE1

  2015cites this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cites this paper
• Cross-talk between heme oxygenase and peroxisome proliferator-activated receptors in the regulation of physiological functions.

  2014cites this paper
• Pathophysiology of Cisplatin-Induced Acute Kidney Injury

  2014cites this paper
• Hepatoprotective effect of silymarin on di(2-ethylhexyl)phthalate (DEHP) induced injury in liver FL83B cells.

  2014cites this paper
• In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA

  2014cites this paper
• A comparison of peroxisome proliferator-activated receptor-α agonist and antagonist on human umbilical vein endothelial cells angiogenesis

  2013cites this paper
• High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.

  2013cites this paper
• Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration.

  2011cites this paper
• Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity

  2009cites this paper
• PPARs in Irradiation-Induced Gastrointestinal Toxicity

  2009cites this paper
• Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

  2009cites this paper
• PPARalpha ligands cause lymphocyte depletion and cell cycle block and this is associated with augmented TRB3 and reduced Cyclin B1 expression.

  2009cites this paper
• Genomics, transcriptomics, proteomics, and numbers.

  2009cites this paper
• Involvement of PPARα in the growth inhibitory effect of arachidonic acid on breast cancer cells

  2008cites this paper
• Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology

  2008cites this paper
• Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene.

  2008cites this paper
• PPARα Ligands as Antitumorigenic and Antiangiogenic Agents

  2008cites this paper
• Differential modulation of PPARalpha and gamma target gene expression in the liver and kidney of rats treated with aspirin.

  2008cites this paper
• Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine‐induced progressive liver carcinogenesis

  2007cites this paper
• Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines

  2007cites this paper
• Cytotoxicity of peroxisome proliferator-activated receptor alpha and gamma agonists in renal proximal tubular cell lines.

  2007cites this paper
• Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.

  2007cites this paper
• Di-(2-ethylhexyl)phthalate and Deep Venous Thrombosis in Children: A Clinical and Experimental Analysis

  2007cites this paper
• 2,4-Dichlorophenoxyacetic acid: effects on Syrian hamster embryo (SHE) cell transformation, c-Myc expression, DNA damage and apoptosis.

  2007cites this paper
• Ligand activation of peroxisome proliferator-activated receptor beta induces terminal differentiation and attenuates colon cancer

  2007cites this paper
• A study of the cytotoxicity of branched-chain phytanic acid with mitochondria and rat brain astrocytes.

  2006cites this paper
• In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling.

  2006cites this paper
• HMG-CoA reductase and PPARα are involved in clofibrate-induced apoptosis in human keratinocytes

  2006cites this paper
• Proposition 65 Maximum Allowable Dose Level ( MADL ) for Reproductive Toxicity for Di ( 2-ethylhexyl ) phthalate ( DEHP ) by Oral Exposure April 2006 Office of Environmental Health Hazard Assessment ( OEHHA ) Reproductive and Cancer Hazard Assessment

  2006cites this paper
• In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

  2006cites this paper
• Key Issues in the Role of Peroxisome Proliferator–Activated Receptor Agonism and Cell Signaling in Trichloroethylene Toxicity

  2006cites this paper
• Mechanism of toxicity of the branched‐chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment

  2006cites this paper
• Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells.

  2005cites this paper
• Proposition 65 Maximum Allowable Dose Level (MADL) for Reproductive Toxicity for Di(2-ethylhexyl)phthalate (DEHP) by Oral Exposure June 2005 Office of Environmental Health Hazard Assessment (OEHHA) Reproductive and Cancer Hazard Assessment Section SUMMARY

  2005cites this paper
• Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23.

  2005cites this paper
• The Refsum disease marker phytanic acid, a branched chain fatty acid, affects Ca2+ homeostasis and mitochondria, and reduces cell viability in rat hippocampal astrocytes.

  2005cites this paper
• Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.

  2005cites this paper
• Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.

  2005cites this paper
• Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.

  2005cites this paper
• Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms.

  2005cites this paper
• Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member g , but not a or d

  2005cites this paper
• Fibrate prevents cisplatin-induced proximal tubule cell death.

  2005cites this paper
• PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.

  2004cites this paper
• Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.

  2004cites this paper
• Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.

  2004cites this paper
• Stress‐ (and Diet‐) Related Regulation of Hepatic Nuclear Receptors and Its Relevance for ABC‐Transporter Functions

  2004cites this paper
• Xenobiotic‐metabolizing Cytochromes P450 in Ontogeny: Evolving Perspective

  2004cites this paper
• Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver.

  2003cites this paper
• The toxicogenomics of nuclear receptor agonists.

  2003cites this paper
• Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans‐10,cis‐12‐linoleic acid

  2003cites this paper
• OPINION OF THE SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE) ON “ASSESSMENT

  2003cites this paper